Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -3.41% is 33% above its 5-year average of -5.06%, around the middle of its 5-year range (-27.84%–14.53%).
166.99% below its 12-month average of 5.09%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2027 (2026-07-31): -1.28%.
RETURN ON ASSETS (ROA)
-3.41%
RETURN ON ASSETS (ROA) AVG TTM
5.09%
RETURN ON ASSETS (ROA) AVG 3Y
-8.30%
RETURN ON ASSETS (ROA) AVG 5Y
-5.06%
RETURN ON ASSETS (ROA) AVG 10Y
-29.48%
RETURN ON ASSETS (ROA) AVG 15Y
-45.39%
RETURN ON ASSETS (ROA) AVG 20Y
-47.52%
CURRENT VS TTM AVG
-166.99%
CURRENT VS 3Y AVG
+58.93%
CURRENT VS 5Y AVG
+32.59%
CURRENT VS 10Y AVG
+88.43%
CURRENT VS 15Y AVG
+92.49%
CURRENT VS 20Y AVG
+92.82%
SECTOR MEDIAN · HEALTHCARE
-26.45%
median of 501 covered companies
CURRENT VS SECTOR MEDIAN
+87.11%
vs the sector median at left
Champions Oncology, Inc.
Market Cap
$69.05M
Return on Assets (ROA)
-3.41%
TTM Avg
5.09%
3Y Avg
-8.30%
5Y Avg
-5.06%
Market Cap
$69.43M
Return on Assets (ROA)
35.31%
TTM Avg
-14.11%
3Y Avg
-23.46%
5Y Avg
-20.68%
Market Cap
$70.01M
Return on Assets (ROA)
-99.89%
TTM Avg
-66.19%
3Y Avg
-52.51%
5Y Avg
-39.81%
Market Cap
$70.03M
Return on Assets (ROA)
-13.50%
TTM Avg
-6.86%
3Y Avg
-33.98%
5Y Avg
-45.40%
Market Cap
$67.11M
Return on Assets (ROA)
-382.32%
TTM Avg
-98.02%
3Y Avg
-80.35%
5Y Avg
-65.77%
Market Cap
$66.56M
Return on Assets (ROA)
-39.17%
TTM Avg
-30.96%
3Y Avg
-31.81%
5Y Avg
-21.33%
Market Cap
$72.02M
Return on Assets (ROA)
-33.34%
TTM Avg
-56.30%
3Y Avg
-89.26%
5Y Avg
-70.59%
Market Cap
$72.09M
Return on Assets (ROA)
-130.37%
TTM Avg
-128.36%
3Y Avg
-112.34%
5Y Avg
-87.04%
Market Cap
$65.08M
Return on Assets (ROA)
-162.91%
TTM Avg
-58.42%
3Y Avg
-64.67%
5Y Avg
-61.98%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Champions Oncology, Inc. (CSBR) | $69.05M | -3.41% | 5.09% | -8.30% | -5.06% |
| Fortress Biotech, Inc. (FBIO)vs › | $69.43M | 35.31% | -14.11% | -23.46% | -20.68% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.01M | -99.89% | -66.19% | -52.51% | -39.81% |
| Heron Therapeutics, Inc. (HRTX)vs › | $70.03M | -13.50% | -6.86% | -33.98% | -45.40% |
| PDS Biotechnology Corporation (PDSB)vs › | $67.11M | -382.32% | -98.02% | -80.35% | -65.77% |
| Alps Group Inc (ALPS)vs › | $66.56M | -39.17% | -30.96% | -31.81% | -21.33% |
| iBio, Inc. (IBIO)vs › | $72.02M | -33.34% | -56.30% | -89.26% | -70.59% |
| Gain Therapeutics, Inc. (GANX)vs › | $72.09M | -130.37% | -128.36% | -112.34% | -87.04% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | -162.91% | -58.42% | -64.67% | -61.98% |
| InterCure Ltd. (INCR)vs › | $64.56M | -5.05% | -7.03% | -4.31% | -4.67% |
ROA
-3.4%
ROE
-29.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-04-30 | -4.35% |
| 2025-04-30 | 14.53% |
| 2024-04-30 | -27.84% |
| 2023-04-30 | -15.55% |
| 2022-04-30 | 1.55% |
| 2021-04-30 | 1.31% |
| 2020-04-30 | -10.09% |
| 2019-04-30 | 1.14% |
| 2018-04-30 | -18.27% |
| 2017-04-30 | -85.93% |
| 2016-04-30 | -180.82% |
| 2015-04-30 | -109.07% |
| 2014-04-30 | -83.52% |
| 2013-04-30 | -54.13% |
| 2012-04-30 | -125.12% |
| 2011-04-30 | -30.06% |
| 2010-04-30 | -74.34% |
| 2009-04-30 | -48.53% |
| 2008-04-30 | -8.84% |
| 2007-04-30 | -92.54% |
| 2006-04-30 | -56244.07% |
| 2005-04-30 | -92.50% |
| 2004-04-30 | -27.48% |
| 2003-04-30 | -29.97% |
| 2002-04-30 | -18.75% |
| 2001-04-30 | -77.25% |
| 2000-04-30 | 3.64% |
| 1999-04-30 | 1.48% |
| 1998-04-30 | 27.07% |
| 1997-04-30 | 29.00% |
